You are here

Mesenchymal Stem Cells

Mesenchymal Stromal Cells Anno 2019

A recently published Concise Review from Martin J.

Carbon Dot-mediated Inhibition of Inflammation Boosts Cartilage Regeneration by MSCs

A study appraises the potential of carbon dots as a replacement for quantum dots to transfect siRNA into MSCs to boost chondrogenic differentiation in vivo

Optimizing Atorvastatin-pretreated MSCs for AMI Treatment

Previous studies from the labs of Li Qian (University of North Carolina at Chapel Hill, USA) and

Cord Tissue MSCs Show Consistency Between Donors

Human umbilical cord tissue represents an excellent source of mesenchymal stem cells (MSCs), and a recent study from the lab of Ian Rogers (Sinai Health System, Toronto, Ontario, Canada) sought to fully characterize can compare cells derived from multiple donors. In their new STEM CELLS Translational Medicine study, Raileanu et al.

Improving Mesenchymal Stem Cell Therapies with TSG‐6

A new study demonstrating how TSG-6 regulates stemness and directs cellular functions in mouse MSCs may allow for improved outcomes in human MSC therapies

UC-MSC Treatment in Children with Autism Spectrum Disorder

Children with autism spectrum disorder (ASD) can suffer from immune dysregulation and inflammation, and now, a STEM CELLS Translational Medicine article from the lab of Neil H.

MSC Therapy for Acute Respiratory Distress Syndrome

A new STEM CELLS Translational Medicine article from the laboratory of

MSC-EVs Improve CD34+ Cell Function

Recent research from the lab of Sandra Muntión (IBSAL‐Hospital Universitario de Salamanca, Salamanca, Spain) aimed to analyze changes induced in human CD34+ hematopoietic stem/progenitor cells following treatment with extracellular vesicles derived from mesenchymal stem cells (MSC-EVs).

Dual Administration Approach for hMSC Therapy Ameliorates ALS Symptoms in Model Rats

New evidence suggests that repeated MSC application protects motor neurons and neuromuscular junctions by inhibiting major cell death pathways in ALS rats

Diabetes Inhibits Bone Regeneration by Autologous Mesenchymal Stem Cell-derived Exosomes

Researchers use a rat model of diabetes to show how the autologous transplantation of MSC exosomes for bone regeneration may be unsuitable in some patients


Subscribe to RSS - Mesenchymal Stem Cells